Registration Deadline approaching: Bacteriophages 2015

Registration includes entry to all the event, lunch and all refreshments, networking opportunities and access to exhibitions

A late registration fee applies after Nov 20th 2014
27 January 2015 – 29 January 2015
This event will discuss the many roles of bacteriophages, ranging from fundamental biological research to their use in medical and industrial biotechnologies.  Topics will include  uses of phages for therapeutics, food manufacture, delivery vectors, drivers of microbiota structure reporters of microbiome diversity, and their  role on the environment
Talks include
European Implementation of Bacteriophage Therapy: Impact of Medicinal Product Legislation on Tailored Hospital Care
Gilbert Verbeken, Queen Astrid Military Hospital, Burn Wound Centre, Brussels, Belgium
Regulation of replication of Shiga toxin-converting bacteriophages
Professor Grzegorz Wegrzyn, Department of Molecular Biology, University of Gdansk, Poland

Bacteriophages for healthy living
Dr Alexander Sulakvelidze, Intralytix, Inc, Baltimore, USA

Phage recombination
Dr Gary Sharples, Fellow of the Wolfson Research Institute for Health and Wellbeing, Visiting Senior Lecturer in the Department of Chemistry, Senior Lecturer in the School of Biological and Biomedical Sciences, Durham University, UK

Talk title to be confirmed
Professor. Dr. Martin J. Loessner, ETH Zurich, Institute of Food, Nutrition and Health, Schmelzbergstrasse 7, Zurich, Switzerland

GMP manufacture of phages for clinical trial
Tony Hitchcock, Technology Director, Cobra Biologics

Overview on Yersinia phages and update on phage therapy initiative in Finland
Professor Mikael Skurnik, Ph.D., Professor of Bacteriology, Haartman Institute, Department of Bacteriology and Immunology, Research Programs Unit, Immunobiology, Helsinki University Central Hospital Laboratory Diagnostics, Finland

Stx prophage control of host phenotypes
Dr. Heather E. Allison, University of Liverpool, BioSciences Building, Crown Street, Liverpool, United KingdomTalk title to be confirmed
Dr Magdalena Plotka, Department of Microbiology, University of Gdansk, Poland, Department of Microbiology, University of Gdansk, Gdansk, Poland

Leveraging bacteriophages for high speed, enrichment-free environmental monitoring
Dr Michael Koeris, Founder, VP Business Development & Operations, Sample6, Inc, Boston, US

Atomic structure of Bordetella phage BPP1 reveals a new topology of the highly conserved HK97-like fold
Professor Z. Hong Zhou, Ph.D., Electron Imaging Center for Nanomachines (EICN), CNSI and Dept of Microbiology, Immun. & Mol. Genetics, UCLA, Los Angeles, CA, USA

Novel polymerases from marine phages
Dr Bin Zhu, Boston, MA, USA

Phage therapy in a post antibiotic era: The savior of the human race or a pie in the sky
Professor. Robert R. Bragg, Dept. of Microbial, Biochemical & Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa

Phage therapy for collibacillosis and salmonellosis for poultry production
Associate Professor. Dr. Sieo Chin Chin, Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia

Dr Jodi A Lindsay, PhD, St George’s, University of London, London, UK

Modern ideas for combating bacteria
Dr Zuzanna Drulis-Kawa PhD., Institute of Genetics and Microbiology, University of Wroclaw, Poland

Dr Paul CM Fogg, University of York, Department of Biology, Wentworth Way, York, UK

Dr Steven Hagens, PhD, Chief Scientific Officer, The Netherlands

Crystal structures of the Fibre Proteins of Bacteriophage T4, T5 and T7
Dr Mark van Raaij, Lab 20B, Madrid, Spain

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: